Connect
Summer Session
Registration for the International Intellectual Property Summer Session is now open for non-WCL students. Those wishing to register should visit the PIJIP page for more information about courses and summer faculty, or to complete the online registration.
Non-WCL students wishing to register for our Geneva courses should complete this online registration.
Email Lists
Alternative Models of Financing Medical Innovation
This blog is the culmination of a semester of work by four PIJIP students, who collected a wide range of literature on different models for the funding of medical research and development. Comments on the analysis and suggestions for other resources are welcomed.
More... (Comments: 0)
NYU Professor Rochelle Dreyfuss to Deliver Fifth Annual Finnegan Lecture on Intellectual Property
Professor Dreyfuss will examine the interaction of the Supreme Court and the First Circuit, asking questions about the role that specialists should be permitted to play in tailoring law to the needs of technologically complex and emerging industries, and the extent to which generalists can helpfully intervene to keep this law in the mainstream and attuned to other social values and related developments, such as open innovation.
More... (Comments: 0)
PIJIP and Prescription Policy Choices Host "Lawyering for Access: Legal Strategies to Improve Access to Affordable Pharmaceuticals"
On October 16, 2009, PIJIP and Prescription Policy Choices will co-host "Lawyering for Access" to discuss actions state governments have taken to control pharmaceutical costs, as well as the roles of legislation and litigation in pharmaceutical policy. Participants will include legal academics, stater government officials, and attorneys involved in landmark pharmaceuticals litigation. CLICK HERE TO VIEW THE WEBCAST
More... (Comments: 0)
Eleven Law Professors and AARP File Breif in Bilski v. Kappos
I recently filed an amicus brief in the pending Supreme Court case, Bilski v. Kappos, about whether business methods are patent eligible “inventions,” on behalf of eleven law professors and AARP. Although the Bilski brief focuses on business methods (and the legal category of unpatentable “abstract ideas”), it also explains how to draw the line between the patentable inventions and unpatentable science and nature.
More... (Comments: 0)
Notes from Monday's PIJIP Event on "Copyright From an International Perspective"
At PIJIP’s event, “Copyright from an International Perspective,” WCL Professors Michael Carroll and Peter Jaszi were joined by Michele Woods, Senior Counsel for Policy and International Affairs at the Office of Policy and International Affairs at US Copyright Office. Professor Jaszi began the panel with a quick introduction to copyright law and the international copyright system...
More... (Comments: 0)
Problematic Provisions in African Anticounterfeiting Legislation
Recent Intellectual Property (IP) legislative acts in the East African Community threaten generic medicines producers with large fines and imprisonment. The Kenyan Anti-Counterfeit Law of 2009, as well as bills that Uganda and the East African Community Legislative Assembly are currently considering, define ‘counterfeit’ so broadly that it includes generic products.
More... (Comments: 0)
Cross-blogging -- IP, India, and Cultural Anthropology
I was recently invited to join the Madisonian.net blog as a contributor. For my first post there, I decided to discuss a recent meeting in Kolkata, India, hosted by a good friend Professor Shamnad Basheer of the National University of Juridical Sciences and the founder of the SpicyIP blog, that considered pending legislation to regulate ownership of inventions created with government funding.
More... (Comments: 0)
KEI Brownbag on Bilski - The Scope of Patentable Subject Matter and Its Effect on the Life Sciences
On September 10, 2009 KEI hosted a brownbag lunch to discuss the scope of patentable subject matter, focusing specifically on the implications for life-science patents of the Supreme Court's forthcoming review of the Bilski Federal Circuit opinion. This is the first time since 1981 that the US Supreme Court will address the limits of patentable subject matter.
More... (Comments: 0)
ACLU Gene Patents Challenge - Bilski Preview
Lori Andrews and I today filed a motion and an amicus brief on behalf of the American Medical Association, the American Society of Human Genetics, the American College of Obstetricians and Gynecologists, the American College of Embryology, and the Medical Society of the State of New York in Association for Molecular Pathology et al. v. U.S. Patent and Trademark Office, et al., No. 09 Civ. 4515 (RWS) -- the lawsuit filed by the ACLU and the Public Patent Foundation challenging the BRCA1 and BRCA2 gene patents owned by Myriad Genetics.
More... (Comments: 0)
CAFTA's Effect on Generic Drugs in Guatemala (New Paper by Ellen Shaffer and Joe Brenner)
A new paper provides empirical evidence that CAFTA's intellectual property provisions requiring data exclusivity have blocked generic products from entering the market, and in some cases forced existing generic products off the market in Guatemala. The paper was presented at the University of California's DC building this afternoon.
More... (Comments: 0)
